Regulatory Prospects for Stem Cell in Clinical Trials: UAE, US, and India
The UAE has made commendable progress in regulating stem cell clinical research. However, the absence of unified national guidelines and inter-emirate coordination remains a challenge. Learning from the centralized frameworks of the U.S. and India can help bridge these gaps. Strengthening oversight will enhance patient safety, ethical compliance, and global collaboration.
Authors
- S Reddy
- Sangita Mishra (ORCID: https://orcid.org/0000-0002-7879-5259)
- Venkatesh MP
Institutions
- JSS Academy of Higher Education and Research (IN)
- UCSI University (MY)
Publication Details
- Journal
- Current Stem Cell Research & Therapy
- Published
- 2025-08-28
- DOI
- https://doi.org/10.2174/011574888x372893250804112424
- Primary Topic
- Biomedical Ethics and Regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00